Zobrazeno 1 - 10
of 109
pro vyhledávání: '"S, Munkvad"'
Publikováno v:
Munkvad, S, Gram, J & Jespersen, J 1992, ' Increase of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in plasma after thrombolytic therapy of patients with myocardial infarction. A randomised, placebo-controlled study ', Fibrinolysis and Proteolysis, vol. 6, no. 1, pp. 45-50 . https://doi.org/10.1016/0268-9499(92)90047-L
Based on recent studies we hypothesised that the marked generation of thrombin in patients who undergo coronary thrombolysis was associated with substantial deviations of endogenous tissue-type plasminogen activator (t-PA) and the plasminogen activat
Publikováno v:
Munkvad, S, Jespersen, J, Gram, J & Kluft, C 1992, ' Association between systemic generation of plasmin and activation of the factor XII-dependent fibrinolytic proactivator system in coronary thrombolysis ', Fibrinolysis and Proteolysis, vol. 6, no. 1, pp. 57-62 . https://doi.org/10.1016/0268-9499(92)90049-N
We have previously reported on a significant decrease of Factor XII-dependent fibrinolytic activity by recombinant tissue-type plasminogen activator (rt-PA) or streptokinase treatment of patients with myocardial infarction. Presently we investigated
Publikováno v:
Hämostaseologie. 11:189-199
ZusammenfassungDieser Bericht gibt einen Überblick über die mit der Entwicklung der ischämischen Herzkrankheit (IH) verbundenen Abweichungen der Hämostase und auch über solche Abweichungen, die für die Entwicklung des akuten ischämischen Herzs
Publikováno v:
Munkvad, S, Gram, J & Jespersen, J 1991, ' Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study ', Scandinavian Journal of Clinical and Laboratory Investigation, vol. 51, no. 7, pp. 581-590 . https://doi.org/10.1080/00365519109104568
In our present placebo-controlled study on recombinant tissue-type plasminogen activator (rt-PA) and heparin treatment of patients with acute ischaemic heart disease (IHD), we studied the extent of fibrin resolution and generation of coagulant activi
Publikováno v:
American Journal of Obstetrics and Gynecology. 163:438-442
Epidemiologic studies have suggested a relationship between the use of oral contraceptives and mortality from cardiovascular diseases in older women. Therefore we studied generation and resolution of fibrin in 28 healthy women above age 30 years, usi
Publikováno v:
Munkvad, S, Gram, J & Jespersen, J 1990, ' A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction ', European Heart Journal, vol. 11, no. 6, pp. 525-528 . https://doi.org/10.1093/oxfordjournals.eurheartj.a059745
The balance between the coagulation system generating fibrin and its subsequent removal by the fibrinolytic system determines the fate of fibrin deposited in the vascular system. In a prospective study, selected haemostatic variables assessing this b
Publikováno v:
Munkvad, S, Jespersen, J, Gram, J, Overgaard, K & Ranby, M 1990, ' Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma ', Clinical Chemistry, vol. 36, no. 5, pp. 737-741 . https://doi.org/10.1093/clinchem/36.5.737
We describe a rapid assay of C1-esterase inhibitor (C1-inh) activity in plasma. After adding purified C1s serine protease (EC 3.4.21.42) in excess to plasma, we determine the residual C1s activity towards a new chromogenic tripeptide, CH3CO-Lys(CbO)-
Publikováno v:
Fibrinolysis. 4:95-99
In a double-blind trial, 56 patients with suspected myocardial infarction (AMI) of a duration of less than 5 h were randomised to either 100 mg recombinant human tissue type plasminogen activator (rt PA) treatment or placebo intravenously over 3 h. W
Autor:
S. Munkvad, M. Jørgensen
Publikováno v:
British Journal of Dermatology. 134:296-298
Summary Patients with leg ulcers caused by venous insufficiency often show evidence of previous deep venous thrombosis. Resistance to activated protein C (APC resistance) is a newly identified, autosomal dominant inherited defect in the anticoagulant
Publikováno v:
Fibrinolysis. 8:189-191
Summary Background: Thrombolytic streptokinase (SK)-therapy produces neutralizing antibodies to SK in about half of the patients; they persist for at least 48 months, thus contraindicating the repeated use of SK within that time in acute myocardial i